Respective effects of phlebotomy losses and erythropoietin treatment on the need for blood transfusion in very premature infants

BACKGROUND: The benefit to risk ratio of the treatment with erythropoietin (EPO) as a means of limiting the number of transfusions in very preterm infants during hospitalization, seems to be modest since the adoption of restrictive transfusion criteria and of policy limiting phlebotomy losses. We th...

Descripción completa

Detalles Bibliográficos
Autores principales: Becquet, Odile, Guyot, Delphine, Kuo, Philippe, Pawlotsky, Françoise, Besnard, Marianne, Papouin, Micheline, Lapillonne, Alexandre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4231464/
https://www.ncbi.nlm.nih.gov/pubmed/24165292
http://dx.doi.org/10.1186/1471-2431-13-176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4231464/
https://www.ncbi.nlm.nih.gov/pubmed/24165292
http://dx.doi.org/10.1186/1471-2431-13-176

Ejemplares similares